Background. The prognosis of IDH1-mutant glioma is significantly better than that of wild-type glioma, and the preoperative identification of IDH mutations in glioma is essential for the formulation of surgical procedures and prognostic assessment. Purpose. To explore the value of a radiomic model based on preoperative-enhanced MR images in the assessment of the IDH1 genotype in high-grade glioma. Materials and Methods. A retrospective analysis was performed on 182 patients with high-grade glioma confirmed by surgical pathology between December 2012 and January 2019 in our hospital with complete preoperative brain-enhanced MR images, including 79 patients with an IDH1 mutation (45 patients with WHO grade III and 34 patients with WHO grade I...
Background and purposeSemantic imaging features have been used for molecular subclassification of hi...
BACKGROUND AND PURPOSE: WHO grade II gliomas are divided into three classes: isocitrate dehydrogenas...
Background: The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS...
Patients with gliomas, isocitrate dehydrogenase 1 (IDH1) mutation status have been studied as a prog...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
Purpose. Preoperative prediction of isocitrate dehydrogenase 1 (IDH1) mutation in lower-grade glioma...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
Background and purposeSemantic imaging features have been used for molecular subclassification of hi...
Background and purposeSemantic imaging features have been used for molecular subclassification of hi...
BACKGROUND AND PURPOSE: WHO grade II gliomas are divided into three classes: isocitrate dehydrogenas...
Background: The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS...
Patients with gliomas, isocitrate dehydrogenase 1 (IDH1) mutation status have been studied as a prog...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
Purpose. Preoperative prediction of isocitrate dehydrogenase 1 (IDH1) mutation in lower-grade glioma...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
Background and purposeSemantic imaging features have been used for molecular subclassification of hi...
Background and purposeSemantic imaging features have been used for molecular subclassification of hi...
BACKGROUND AND PURPOSE: WHO grade II gliomas are divided into three classes: isocitrate dehydrogenas...
Background: The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS...